<DOC>
	<DOCNO>NCT00296179</DOCNO>
	<brief_summary>To demonstrate overall improvement insomnia subject treat zolpidem tartrate extended-release ( Ambien CR ) escitalopram ( Lexapro ) vs. subject treat placebo escitalopram 2 month .</brief_summary>
	<brief_title>Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>MAJOR INCLUSION CRITERIA : 1 . Must experience sleep disturbance least 3 nights/week , base historical data 2 . Must meet diagnostic requirement Major Depressive Disorder 3 . Must QIDSSR16 score 6 15 4 . Must either newly diagnose show symptom relapse/recurrence depression medication 5 . Age 2164 , inclusive 6 . Women must use medically acceptable form contraception ( steroidal contraceptive , doublebarrier , intrauterine device ) entire study period , : surgically sterilize , postmenopausal , agree use doublebarrier contraception throughout study period , must negative urine pregnancy test prior randomization . 7 . Subject must stabilize ongoing longterm medication therapy least 28 day prior screen visit . MAJOR EXCLUSION CRITERIA : 1 . Severity depressive episode rat `` severe '' `` severe psychotic feature . '' 2 . History suicide attempt suicidal ideation . 3 . History mania , manic episode bipolar disease . 4 . Currently use benzodiazepine SSRI 2 day use within 28 day precede randomization . 5 . Use prescription nonprescription sedative drug give purpose sleep induction relieve jet lag 6 . Any abnormal prestudy laboratory value require clinical intervention 7 . Prior failure respond escitalopram therapy depression 8 . Current depressive episode require inpatient hospitalization . 9 . Shift work requirement regular change sleep schedule least six hour within previous 28 day . 10 . History drug addiction , alcoholism , drug abuse . 11 . A positive urine drug screen medication would interfere assessment study medication . 12 . Known allergy zolpidem , escitalopram excipients 13 . History sleep apnea 14 . History myasthenia gravis 15 . The presence untreated uncompensated clinically significant renal , endocrine , gastrointestinal , hepatic , respiratory , cardiovascular , neurologic , hematologic , oncologic , immunologic , cerebrovascular disease malignancy . 16 . Pregnant breastfeed 17 . Subject participate another clinical trial , complete another clinical trial within 28 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>